Literature DB >> 24752656

The self-administration of rapidly delivered cocaine promotes increased motivation to take the drug: contributions of prior levels of operant responding and cocaine intake.

Karim Bouayad-Gervais1, Ellie-Anna Minogianis, Daniel Lévesque, Anne-Noël Samaha.   

Abstract

RATIONALE: Rapid drug delivery to the brain might increase the risk for developing addiction. In rats, increasing the speed of intravenous cocaine delivery (5 vs. 90 s) increases drug intake and the subsequent motivation to self-administer cocaine. Increased motivation for cocaine could result not only from more extensive prior drug intake and operant responding for drug, but also from neuroplasticity evoked by rapid drug uptake.
OBJECTIVE: We determined the contributions of prior drug intake and operant responding to the increased motivation for cocaine evoked by rapid delivery. We also investigated the effects of cocaine delivery speed on corticostriatal expression of brain-derived neurotrophic factor (BDNF) and tropomyosin receptor kinase B (TrkB) mRNA.
METHODS: Rats self-administered cocaine (0.25 mg/kg/infusion) delivered over 5 or 90 s during short-access (1 h/session; ShA) or long-access (6 h; LgA) sessions. Motivation for cocaine was then assessed by measuring responding under a progressive ratio schedule of reinforcement. Next, BDNF and TrkB mRNA levels were measured in 5- and 90-s rats.
RESULTS: Five-second ShA and 5-s-LgA rats were more motivated for cocaine than their 90-s counterparts. This effect was dissociable from previous levels of drug intake or of operant responding for cocaine. In parallel, only rats self-administering rapid cocaine injections had altered BDNF and TrkB mRNA levels in corticostriatal regions.
CONCLUSIONS: Rapid drug delivery augments the motivation for cocaine independently of effects on the levels of drug intake or operant responding for drug. We suggest that rapid delivery might increase the motivation for drug by promoting neuroplasticity within reward pathways. This neuroplasticity could involve increased regulation of BDNF/TrkB.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24752656     DOI: 10.1007/s00213-014-3576-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  73 in total

Review 1.  The pharmacology of cocaine smoking in humans.

Authors:  R T Jones
Journal:  NIDA Res Monogr       Date:  1990

2.  Risk of becoming cocaine dependent: epidemiological estimates for the United States, 2000-2001.

Authors:  Megan S O'Brien; James C Anthony
Journal:  Neuropsychopharmacology       Date:  2005-05       Impact factor: 7.853

3.  Alpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access.

Authors:  Sunmee Wee; Chitra D Mandyam; Dusan M Lekic; George F Koob
Journal:  Eur Neuropsychopharmacol       Date:  2007-10-24       Impact factor: 4.600

Review 4.  Goal-directed instrumental action: contingency and incentive learning and their cortical substrates.

Authors:  B W Balleine; A Dickinson
Journal:  Neuropharmacology       Date:  1998 Apr-May       Impact factor: 5.250

Review 5.  Cocaine addiction: psychology and neurophysiology.

Authors:  F H Gawin
Journal:  Science       Date:  1991-03-29       Impact factor: 47.728

6.  A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning.

Authors:  Bernard Le Foll; Jorge Diaz; Pierre Sokoloff
Journal:  Neuroreport       Date:  2005-02-08       Impact factor: 1.837

7.  Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving.

Authors:  Jeffrey W Grimm; Lin Lu; Teruo Hayashi; Bruce T Hope; Tsung-Ping Su; Yavin Shaham
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

8.  Evidence for addiction-like behavior in the rat.

Authors:  Véronique Deroche-Gamonet; David Belin; Pier Vincenzo Piazza
Journal:  Science       Date:  2004-08-13       Impact factor: 47.728

9.  The speed of cocaine delivery determines the subsequent motivation to self-administer the drug.

Authors:  Ellie-Anna Minogianis; Daniel Lévesque; Anne-Noël Samaha
Journal:  Neuropsychopharmacology       Date:  2013-07-18       Impact factor: 7.853

10.  Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse.

Authors:  Danielle L Graham; Scott Edwards; Ryan K Bachtell; Ralph J DiLeone; Maribel Rios; David W Self
Journal:  Nat Neurosci       Date:  2007-07-08       Impact factor: 24.884

View more
  5 in total

1.  Intermittent intake of rapid cocaine injections promotes the risk of relapse and increases mesocorticolimbic BDNF levels during abstinence.

Authors:  Aliou B Gueye; Florence Allain; Anne-Noël Samaha
Journal:  Neuropsychopharmacology       Date:  2018-10-26       Impact factor: 7.853

2.  High and escalating levels of cocaine intake are dissociable from subsequent incentive motivation for the drug in rats.

Authors:  Florence Allain; Karim Bouayad-Gervais; Anne-Noël Samaha
Journal:  Psychopharmacology (Berl)       Date:  2017-10-31       Impact factor: 4.530

3.  Impact of delivery rate on the acute response to intravenous nicotine: A human laboratory study with implications for regulatory science.

Authors:  Joao P De Aquino; R Ross MacLean; Ralitza Gueorguieva; Elise E DeVito; Tore Eid; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2022-03       Impact factor: 4.280

4.  Varying the rate of intravenous cocaine infusion influences the temporal dynamics of both drug and dopamine concentrations in the striatum.

Authors:  Ellie-Anna Minogianis; Waqqas M Shams; Omar S Mabrouk; Jenny-Marie T Wong; Wayne G Brake; Robert T Kennedy; Patrick du Souich; Anne-Noël Samaha
Journal:  Eur J Neurosci       Date:  2018-07-24       Impact factor: 3.386

5.  Brief intermittent cocaine self-administration and abstinence sensitizes cocaine effects on the dopamine transporter and increases drug seeking.

Authors:  Erin S Calipari; Cody A Siciliano; Benjamin A Zimmer; Sara R Jones
Journal:  Neuropsychopharmacology       Date:  2014-09-12       Impact factor: 7.853

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.